Home › Funds › Atle Fund Management AB › ONC
Atle Fund Management AB position in ONC
BEONE MEDICINES LTD · Health Care
Atle Fund Management AB reported holding 35,679 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$13.1M, representing 3.50% of its reported portfolio and ranking #9 among its reported holdings. Atle Fund Management AB has disclosed ONC holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Atle Fund Management AB's ONC position evolved
Atle Fund Management AB first disclosed a stake in ONC in Q4 2024 at 10,900 shares (US$2.0M). The position peaked in Q3 2026 at 35,679 shares, worth US$13.1M. Across 8 filings, Atle Fund Management AB increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 35,679 shares valued at US$13.1M — an increase of 499 shares quarter over quarter.. Notable position changes include a 131% increase in Q1 2025 (shares fell 11% over the following quarter), a 33% increase in Q4 2025 (shares fell 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 10.90K | $2.00M | New |
| Q1 2025 | 25.14K | $6.84M | Add |
| Q2 2025 | 24.39K | $5.90M | Reduce |
| Q3 2025 | 30.33K | $1.10M | Add |
| Q4 2025 | 40.43K | $12.28M | Add |
| Q1 2026 | 41.72K | $12.14M | Add |
| Q2 2026 | 35.18K | $10.03M | Reduce |
| Q3 2026 | 35.68K | $13.06M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONC and 13F data
ONC (BEONE MEDICINES LTD) is a Health Care company. 28 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.43B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ONC
- BAKER BROS. ADVISORS LP 8.80M sh · $2.51B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 5.01M sh · $1.43B · Q2 2026
- Temasek Holdings 845.73K sh · $241.01M · Q2 2026
- Temasek Holdings (Private) Ltd 845.73K sh · $241.01M · Q2 2026
- Siren, L.L.C. 465.00K sh · $170.16M · Q3 2026
- Capital International, Inc./CA/ 305.48K sh · $87.05M · Q2 2026
- Capital International Sarl 175.54K sh · $50.02M · Q2 2026
More on Atle Fund Management AB
FAQ
How long has Atle Fund Management AB held ONC?
Atle Fund Management AB has disclosed ONC holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Atle Fund Management AB's current position in ONC?
As of Q3 2026, Atle Fund Management AB holds 35.68K shares of ONC (BEONE MEDICINES LTD), valued at $13.06M, representing 3.50% of its reported portfolio and ranking #9.
Has Atle Fund Management AB been buying or selling ONC?
In the latest 13F filing (Q3 2026), Atle Fund Management AB increased its position in ONC. The position peaked in Q3 2026 at 35.68K shares.
Which other funds hold ONC?
Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.